Clinical trial Recruiting at 1 site Phase 4 Interventional Ages 18 and up Women only

Routine antiemetic prophylaxis for non-fasted parturients having cesarean delivery with spinal anesthesia

Official title: Comparative Effectiveness of Routine Antiemetic Prophylaxis in Nonfasted Parturients Undergoing Cesarean Sections Under Spinal Anesthesia: A Prospective Randomized Controlled Trial

Run by Sanliurfa Education and Research Hospital · NCT07740577 · Data updated 2026-11-12

This trial tests whether giving a preventive antiemetic approach (ondansetron or a metoclopramide) reduces intraoperative nausea and vomiting in non-fasted women having emergency cesarean sections under spinal anesthesia.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment120 (estimated)
SponsorSanliurfa Education and Research Hospital
Government
Locations1 site (Sanliurfa, Eyyübiye)
StatusRecruiting
StartedJuly 30, 2026
Main results expectedJanuary 1, 2027
Study endsJanuary 2, 2027
Registry record updatedOctober 1, 2026
Trial IDNCT07740577 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are non-fasted, ASA I-II pregnant women undergoing emergency cesarean delivery under spinal anesthesia who consent to participate.

Probably not a fit

Patients who do not experience nausea and vomiting or who have contraindications to the study drugs may derive no direct benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, double-blind study, non-fasted parturients undergoing emergency cesarean delivery under spinal anesthesia are assigned to receive either a 5-HT3 receptor antagonist or a dopamine receptor antagonist as routine antiemetic prophylaxis to prevent intraoperative nausea and vomiting. Eligible participants are ASA I-II pregnant women aged 18 or older with a singleton pregnancy. Participants and clinicians are blinded to treatment allocation, and outcomes focus on the incidence of intraoperative nausea and vomiting. The study aims to optimize antiemetic strategies to improve maternal comfort and perioperative safety during emergency cesarean deliveries.

Why it matters

Potential benefit: If successful, the approach could reduce intraoperative nausea and vomiting and improve maternal comfort and perioperative safety during cesarean delivery.

How similar studies have gone: Previous work has explored antiemetic prophylaxis in obstetric anesthesia, but direct comparisons between 5-HT3 antagonists and dopamine antagonists in this specific setting are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women scheduled for emergency cesarean delivery under spinal anesthesia
* Non-fasted (full-stomach) parturients
* American Society of Anesthesiologists (ASA) physical status I-II
* Age ≥ 18 years
* Singleton pregnancy
* Ability to provide written informed consent

Exclusion Criteria:

* ASA physical status III or higher
* Refusal to participate
* Elective cesarean delivery (non-emergency cases)
* Preoperative antiemetic use within 24 hours before surgery
* Known allergy or contraindication to study drugs (ondansetron or metoclopramide)
* Pre-existing gastrointestinal disorders (e.g., severe GERD, gastroparesis, bowel obstruction)
* Psychiatric illness or current use of psychotropic medications
* Preoperative anemia (as defined by institutional threshold, e.g., Hb \< 10 g/dL)
* Intraoperative conversion to general anesthesia
* Massive intraoperative hemorrhage (\>1000-1500 mL or requiring transfusion, depending on your protocol definition)
* Intraoperative administration of additional sedative or antiemetic agents outside study protocol
* Multiple gestation pregnancies

Where it's running

  • Sanliurfa Education and Research Hospital
    Sanliurfa, Eyyübiye, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.